Explanatory Report by the Management Board on Key Features of the Internal Control and Risk Management System Related to the Group Accounting Procedures of the Company Pursuant to Section 289 (5), Section 315 (2) HGB (German version)

Further information

Review

Epigenomics AG held its 10th Annual General Shareholders’ Meeting in Berlin with about 50 shareholders, its representatives and guests on June 3, 2014. The presence before the voting was at 2,886,943 individual shares, equivalent to 21.368% of the share capital.

All agenda items were agreed to. More detailed information are available on our German website.